Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 07-2010 | 07-2009 | 07-2008 | 07-2007 | 07-2006 | |
| Sales | 1,436 | 728 | 1,488 | 336 | 200 |
| Cost of Goods | 465 | 238 | 464 | 221 | 106 |
| Gross Profit | 971 | 490 | 1,024 | 115 | 95 |
| Operating Expenses | 8,347 | 7,863 | 8,168 | 5,177 | 3,913 |
| Operating Income | -6,911 | -7,134 | -6,680 | -4,841 | -3,713 |
| Interest Expense | 0 | 0 | 0 | 0 | 1 |
| Other Income | 151 | 70 | 143 | 188 | 33 |
| Pre-tax Income | -6,760 | -7,065 | -6,538 | -4,653 | -3,681 |
| Income Tax | N/A | -2 | 2 | 2 | 132 |
| Net Income Continuous | -6,760 | -7,063 | -6,540 | -4,655 | -3,813 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 130 |
| Net Income | $-6,760 | $-7,063 | $-6,540 | $-4,655 | $-3,683 |
| EPS Basic Total Ops | -1.60 | -1.84 | -1.92 | -1.52 | -1.44 |
| EPS Basic Continuous Ops | -1.57 | -1.85 | -1.90 | -1.52 | -1.52 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.08 |
| EPS Diluted Total Ops | -1.60 | -1.84 | -1.92 | -1.52 | -1.44 |
| EPS Diluted Continuous Ops | -1.57 | -1.85 | -1.90 | -1.52 | -1.52 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.08 |
| EBITDA(a) | $-6,442 | $-6,687 | $-6,275 | $-4,584 | $-3,455 |